Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 21 March 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces...
Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 16 March 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that...
Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 23 November 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company...
PROTHERICS ANNOUNCES PRELIMINARY RESULTS FOR YEAR ENDED 31 MARCH 2008 Strong increase in underlying revenues and robust financial position Solid progress across...
PROTHERICS PLC NOTIFICATION OF MAJOR INTERESTS IN SHARES 25 January 2006: Protherics PLC, the biopharmaceutical company focused on critical care and oncology (the "Company"), received notification on...
Last December, when Protherics' chief executive Andrew Heath announced that he had eight out of 20 of the world's biggest pharmaceutical companies interested in licensing its sepsis product, Cytofab, the shares reacted positively. But when nothing ha Last December, when Protherics' chief executive Andrew Heath ...
Protherics' share price had been hit by a lack of news on its efforts to secure a marketing deal for its antisepsis drug, CytoFab. So the shares leapt on the announcement accompanying these half-year figures that a deal had been done with AstraZeneca Protherics' share price...
Protherics has snapped up the marketing rights for heart drug Digitalis Antidot from Roche. The company plans to replace Roche's product with its own drug, Digifab, early next year. Roche's drug is sold in Germany, France and Switzerland, and both pr Protherics has snapped up the...
WHILE THE UNITED STATES HAS HISTORICALLY been a dominant player in the field of biotech research, innovation and commercialization, other global communities are striving toward new levels of achievement. Europe is no exception. WHILE THE UNITED STATES HAS HISTORICALLY been a dominant player...